Miami Zantac Lawyer

Ranitidine, sold for decades under the brand name Zantac, was one of the most widely prescribed heartburn medications in the world. The FDA’s 2020 recall of all ranitidine products changed everything for millions of people who had taken it for years, sometimes at a doctor’s direction and sometimes over the counter. The agency’s finding centered on NDMA, a probable human carcinogen that can accumulate in ranitidine molecules over time and through heat exposure, potentially reaching levels far above what regulators consider safe. For people in Miami and across Florida who were diagnosed with cancer after prolonged Zantac use, the question now is whether that medication contributed to what happened to them, and whether the companies that made and sold it should be held responsible. Spencer Morgan Law represents injury victims, and pharmaceutical cases like this one sit at the intersection of complex corporate misconduct and very real physical harm to real people.

What the Science and Regulatory Record Actually Show

The NDMA problem with ranitidine was not discovered overnight. Independent researchers began publishing findings about ranitidine instability years before the FDA acted, and some of those researchers flagged the issue to regulators long before a formal recall was announced. What emerged from the scientific record is that NDMA does not simply exist as a manufacturing contaminant in ranitidine the way it does in some other recalled drugs. Instead, the ranitidine molecule itself can degrade and produce NDMA over time, particularly when exposed to heat or when stored for extended periods. This means that a pill that tested within acceptable limits when it left the factory could have accumulated dangerous NDMA levels by the time someone took it.

The types of cancer that researchers and litigants have focused on in Zantac litigation include cancers of organs that process, store, or come into contact with ingested substances and their metabolites. Cases have concentrated on bladder cancer, stomach cancer, esophageal cancer, liver cancer, pancreatic cancer, and kidney cancer, among others. Whether any individual’s cancer was caused or contributed to by ranitidine is a question that depends on the duration and dosage of use, the timing of diagnosis relative to use, and the individual’s broader medical history. Those are exactly the kinds of fact-specific determinations that litigation is designed to work through.

• FDA testing showed some ranitidine samples contained NDMA at levels significantly higher than the 96 nanogram daily intake limit the agency considers acceptable.
• Bladder, stomach, esophageal, liver, pancreatic, and kidney cancers have been the primary focus of Zantac injury claims.
• Statute of limitations deadlines in Florida apply to these claims, and the clock typically begins when the injury is or should have been discovered.
• Potential defendants include brand-name manufacturers like Sanofi and GSK, as well as generic manufacturers and major retail pharmacies that distributed store-brand ranitidine.
• Establishing causation requires medical records, prescription and purchase history, expert testimony, and evidence of the duration and form of ranitidine use.

The litigation landscape for Zantac has been unusually complicated. A large federal MDL (multidistrict litigation) was initially consolidated in the Southern District of Florida, which is the federal judicial district that covers Miami. That court ultimately dismissed the federal MDL cases based on the expert testimony presented at that stage, but state court litigation has continued aggressively in courts across the country, including in Florida. The dismissal of the federal MDL was not a ruling that Zantac does not cause cancer. It was a ruling about the specific scientific methodology used by the plaintiffs’ experts in that particular proceeding. State court cases have proceeded on different expert foundations and have produced different outcomes.

Florida State Court Cases and Where Miami Zantac Claims Stand

Florida has been one of the most active states for Zantac litigation outside the federal MDL. Cases have been filed in state courts throughout the state, and several have proceeded to bellwether trial status, meaning they were selected to be tried early in order to give both sides a sense of how juries respond to the evidence. For Miami residents, Zantac claims would typically be filed in Miami-Dade Circuit Court or potentially in federal court depending on the parties involved and how the case is structured. Spencer Morgan Law has extensive familiarity with Miami-Dade courts and the litigation environment here, which matters when you are talking about expert witness preparation, local discovery practice, and how cases actually move.

One important development in the state court litigation has been the focus on specific cancer types. Not every cancer that someone who took Zantac has been developed is being pursued with equal scientific support. The strongest body of evidence, and therefore the most developed litigation, has centered on a core group of cancers. That does not mean other cancer diagnoses cannot be pursued, but it does mean that the quality of the causation evidence matters enormously to how a case is built and how likely it is to succeed. This is precisely why legal evaluation of a Zantac cancer case should happen before conclusions are drawn about what is or is not viable.

Florida’s statute of limitations for personal injury claims is generally four years from the date of injury or discovery, but pharmaceutical cases can raise genuinely complex questions about when the clock started. Someone who took Zantac in the late 2000s but was not diagnosed with cancer until recently, or who did not connect their diagnosis to the medication until hearing about the recall, may have a longer window than they realize. Someone who was diagnosed years ago and has been aware of the Zantac connection may have a tighter situation. Getting an honest assessment of where a claim stands procedurally is part of what an attorney evaluation should accomplish.

What Zantac Cancer Victims in Miami Should Know About Proving Their Case

The foundation of any Zantac injury claim is documentation. That means prescription records, pharmacy fill histories, receipts or purchase records if the medication was bought over the counter, and the complete medical history surrounding the cancer diagnosis and treatment. Many people took Zantac for years without a prescription and may not have obvious paper records of their use. In those situations, personal records, bank and credit card statements from pharmacies, and witness accounts can help establish the duration and pattern of use. Building this record early matters because memories fade and documentation becomes harder to gather over time.

Expert testimony is the other foundational pillar. Pharmaceutical product liability cases live and die on whether credible scientific experts can explain, in terms a jury can understand and find persuasive, how NDMA forms in ranitidine, how it causes DNA damage, and why this plaintiff’s cancer is consistent with that mechanism. The federal MDL dismissal was driven largely by a judicial finding that the plaintiffs’ causation experts had not used reliable methodology. State court cases that have gone forward successfully have done so in part because the scientific presentation was handled differently. Choosing legal representation that takes expert selection and preparation seriously is not a minor consideration. It may be the most consequential one.

Damages in a Zantac cancer case can be substantial. Cancer treatment costs, including surgery, chemotherapy, radiation, and ongoing monitoring, can reach hundreds of thousands of dollars or more. Lost income, both past and future, is recoverable where the illness has affected a person’s ability to work. Pain and suffering, loss of enjoyment of life, and where a spouse is involved, loss of consortium are all recognized elements of damages in Florida. In cases involving death, a wrongful death claim can be brought by the surviving family. The goal is to account for the full scope of what this illness has cost the victim and their family, not just the medical bills that are easiest to quantify.

Answers to Questions We Hear Most Often From Potential Clients

Does taking Zantac automatically mean I have a claim?

Not automatically. A viable claim requires both a qualifying cancer diagnosis and a sufficient history of ranitidine use. The strength of the connection between your specific cancer type and ranitidine, along with how long and how much you used the drug, determines whether a claim has realistic legs. An evaluation will look at all of those factors before drawing any conclusions.

What if I only used over-the-counter Zantac, not a prescription version?

Over-the-counter use is still the basis for a claim. Both prescription and OTC ranitidine products were recalled. The challenge with OTC use is often documentation, since there are no pharmacy fill records in the same way there are for prescriptions. Purchase history from retailers, personal diaries or calendars, and statements from family members can all help establish a history of use.

Was the federal MDL dismissal a loss for all Zantac cases?

No. The federal MDL dismissal was a ruling about how specific expert testimony was presented in that specific proceeding. It did not resolve the underlying scientific question of whether Zantac causes cancer, and it did not bar state court litigation. State courts across Florida and the country have continued to allow Zantac cases to proceed, and some have gone to trial. The litigation is very much ongoing.

How long do I have to file a claim in Florida?

Florida’s general personal injury statute of limitations is four years, but the calculation of when that period begins in a pharmaceutical case can be genuinely complicated. The discovery rule can extend the window when someone did not and could not reasonably have known about the connection between their cancer and Zantac. Getting a legal evaluation sooner rather than later is the only way to know where you actually stand on timing.

What if the person who used Zantac has already passed away?

A wrongful death claim can be brought on behalf of the estate and surviving family members. Florida’s Wrongful Death Act allows recovery for medical expenses, lost financial support, loss of companionship, and pain and suffering, among other damages. The claim would be brought by the personal representative of the estate, typically a surviving spouse or adult child.

Will this case go to trial, or is a settlement more likely?

Pharmaceutical litigation of this scale typically resolves through a mix of trials and settlements. Some bellwether cases go to verdict, and those outcomes influence how settlement negotiations proceed for other cases. Whether any individual case settles or goes to trial depends on the defendant’s posture, the strength of the evidence, and the client’s priorities. There is no universal answer, and anyone who tells you otherwise at the outset is overpromising.

Does Spencer Morgan Law handle cases on contingency?

Yes. Spencer Morgan Law handles personal injury cases on a contingency fee basis, meaning no fees are charged unless and until there is a recovery. This applies to pharmaceutical injury cases as it does to other injury claims the firm handles.

Speak With a Miami Ranitidine Cancer Attorney

Zantac litigation is scientifically complex, procedurally complicated, and genuinely consequential for the people at the center of it. Spencer Morgan Law has spent more than two decades representing injury victims in Miami and South Florida, handling cases involving serious harm caused by the negligence of corporations and institutions. If you or someone in your family developed cancer after prolonged ranitidine use, a confidential consultation can help you understand what your situation actually looks like and what your realistic options are. There is no obligation, no fee to speak with us, and no cost unless we recover for you. Reach out to Spencer Morgan Law to have a Miami ranitidine cancer attorney review your case.